CAT
Caterpillar Inc.
CAT has the edge over DOV overall, supported by stronger modeled upside and stronger fundamentals.
DOV
Dover Corporation
DOV's outlook is improving, though it still trails on the overall score.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
DOV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
DOV's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over DOV in the historical PE scenario, which offers more potential upside but is not a forecast.
DOV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $134 | -36% |
| Forward | 18x | $209 | — |
| Fair | 20x | $169 | -19% |
| Current | 24x | $209 | — |
| Expensive | 27x | $229 | +9.1% |
Historical ranges are pointers, not guarantees.
DOV's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its fair range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
DOV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for DOV, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
DOV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.59 | +35% |
| Q3 2026 | $8.58 | -47% |
| Q2 2026 | $8.30 | -50% |
| Q1 2026 | $8.02 | -52% |
| Q4 2025 | $7.94 | -59% |
| Q3 2025 | $16.26 | +45% |
| Q2 2025 | $16.58 | +55% |
| Q1 2025 | $16.60 | +59% |
| Q4 2024 | $19.45 | +159% |
DOV has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over DOV on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over DOV on profitability, with a higher operating margin.
DOV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +7.5% |
| Q2 2026 | $2.2B | +6.9% |
| Q1 2026 | $2.1B | +10% |
| Q4 2025 | $2.1B | +8.8% |
| Q3 2025 | $2.1B | +4.8% |
| Q2 2025 | $2B | -5.9% |
| Q1 2025 | $1.9B | -11% |
| Q4 2024 | $1.9B | -8.4% |
DOV's revenue has grown year over year for five quarters in a row: $2.2B last quarter, up 7.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +0.6 points |
| Q2 2026 | 18% | +0.6 points |
| Q1 2026 | 15% | -1 points |
| Q4 2025 | 16% | +1.2 points |
| Q3 2025 | 18% | +1.3 points |
| Q2 2025 | 17% | +0.3 points |
| Q1 2025 | 16% | +1.8 points |
| Q4 2024 | 15% | -1.5 points |
DOV's operating margin was 19% last quarter, up 0.6 points from the same quarter a year ago, near the top of its range since 2019.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
DOV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $383.3M | +3.6% |
| Q2 2026 | $188.4M | +24% |
| Q1 2026 | $131.2M | +20% |
| Q4 2025 | $487M | +26% |
| Q3 2025 | $370.1M | +48% |
| Q2 2025 | $151.4M | -7% |
| Q1 2025 | $109.3M | -11% |
| Q4 2024 | $385M | -15% |
DOV has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
DOV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -675K shares |
| 1 year | -2.3% | -3.2M shares |
| 3 years | -4.1% | -5.7M shares |
| 5 years | -7.3% | -10.6M shares |
| Available history | -8.2% | -12.1M shares |
DOV has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $331.6M |
| Q2 2026 | — |
| Q1 2026 | $53.9M |
| Q4 2025 | $500M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $40.7M |
| Q4 2024 | — |
DOV spent $886M buying back its own shares over the past year, more than ten times what it spent the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over DOV on leverage, with a lower net debt burden relative to earnings.
DOV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.9x | Very low |
DOV's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DOV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.6 | Neutral |
| Stochastic | 70.7 | Neutral |
DOV's weekly RSI is 56 (neutral) and its Stochastic is 71 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over DOV on valuation relative to its sector.
DOV PE vs Industrials Sector
| Metric | DOV | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.4% above |
| PE % | 70 | 58 | 12 pts above |
DOV is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
DOV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $198.3 | 5.6% above |
| 20 week MA | $201.2 | 4.1% above |
| 50 week MA | $207.8 | 0.8% above |
| 100 week MA | $194.3 | 7.8% above |
| 200 week MA | $178.0 | 18% above |
DOV has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
DOV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $115.5 | $124.0 | +7.4% |
| 2021 | $124.0 | $173.7 | +40% |
| 2022 | $173.7 | $134.7 | -22% |
| 2023 | $134.7 | $153.8 | +14% |
| 2024 | $153.8 | $188.3 | +22% |
| 2025 | $188.3 | $200.2 | +6.3% |
| 2026 YTD | $200.2 | $209.5 | +4.7% |
DOV has the edge over CAT on returns for 2026, with the stronger performance.